0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Allergic Rhinitis Medication - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: April 2024
|
Report Code: QYRE-Auto-2C14404
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Allergic Rhinitis Medication Market Research Report 2023
BUY CHAPTERS

Allergic Rhinitis Medication - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-2C14404
Report
April 2024
Pages:125
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Allergic Rhinitis Medication - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Allergic Rhinitis Medication - Market

Allergic Rhinitis Medication - Market

The global market for Allergic Rhinitis Medication was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Allergic Rhinitis Medication, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Allergic Rhinitis Medication by region & country, by Type, and by Application.
The Allergic Rhinitis Medication market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Allergic Rhinitis Medication.
Market Segmentation

Scope of Allergic Rhinitis Medication - Market Report

Report Metric Details
Report Name Allergic Rhinitis Medication - Market
CAGR 5%
Segment by Type:
  • Antihistamines
  • Nasal Spray Steroids
  • Antileukotrienes
Segment by Application
  • Seasonal Allergies
  • Perennial Allergies
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Stallergenes Greer, AstraZeneca, Lotus, GSK, Neurent Medical, Hikma Pharmaceuticals, Med Globe Therapeutics Limited, Bayer Global, Taiho Pharmaceutical, Regeneron Pharmaceuticals, Glenmark
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Allergic Rhinitis Medication manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Allergic Rhinitis Medication in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Allergic Rhinitis Medication in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Allergic Rhinitis Medication - Market report?

Ans: The main players in the Allergic Rhinitis Medication - Market are Stallergenes Greer, AstraZeneca, Lotus, GSK, Neurent Medical, Hikma Pharmaceuticals, Med Globe Therapeutics Limited, Bayer Global, Taiho Pharmaceutical, Regeneron Pharmaceuticals, Glenmark

What are the Application segmentation covered in the Allergic Rhinitis Medication - Market report?

Ans: The Applications covered in the Allergic Rhinitis Medication - Market report are Seasonal Allergies, Perennial Allergies

What are the Type segmentation covered in the Allergic Rhinitis Medication - Market report?

Ans: The Types covered in the Allergic Rhinitis Medication - Market report are Antihistamines, Nasal Spray Steroids, Antileukotrienes

1 Market Overview
1.1 Allergic Rhinitis Medication Product Introduction
1.2 Global Allergic Rhinitis Medication Market Size Forecast
1.2.1 Global Allergic Rhinitis Medication Sales Value (2019-2030)
1.2.2 Global Allergic Rhinitis Medication Sales Volume (2019-2030)
1.2.3 Global Allergic Rhinitis Medication Sales Price (2019-2030)
1.3 Allergic Rhinitis Medication Market Trends & Drivers
1.3.1 Allergic Rhinitis Medication Industry Trends
1.3.2 Allergic Rhinitis Medication Market Drivers & Opportunity
1.3.3 Allergic Rhinitis Medication Market Challenges
1.3.4 Allergic Rhinitis Medication Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Allergic Rhinitis Medication Players Revenue Ranking (2023)
2.2 Global Allergic Rhinitis Medication Revenue by Company (2019-2024)
2.3 Global Allergic Rhinitis Medication Players Sales Volume Ranking (2023)
2.4 Global Allergic Rhinitis Medication Sales Volume by Company Players (2019-2024)
2.5 Global Allergic Rhinitis Medication Average Price by Company (2019-2024)
2.6 Key Manufacturers Allergic Rhinitis Medication Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Allergic Rhinitis Medication Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Allergic Rhinitis Medication
2.9 Allergic Rhinitis Medication Market Competitive Analysis
2.9.1 Allergic Rhinitis Medication Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Allergic Rhinitis Medication Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Allergic Rhinitis Medication as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Antihistamines
3.1.2 Nasal Spray Steroids
3.1.3 Antileukotrienes
3.2 Global Allergic Rhinitis Medication Sales Value by Type
3.2.1 Global Allergic Rhinitis Medication Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Allergic Rhinitis Medication Sales Value, by Type (2019-2030)
3.2.3 Global Allergic Rhinitis Medication Sales Value, by Type (%) (2019-2030)
3.3 Global Allergic Rhinitis Medication Sales Volume by Type
3.3.1 Global Allergic Rhinitis Medication Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Allergic Rhinitis Medication Sales Volume, by Type (2019-2030)
3.3.3 Global Allergic Rhinitis Medication Sales Volume, by Type (%) (2019-2030)
3.4 Global Allergic Rhinitis Medication Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Seasonal Allergies
4.1.2 Perennial Allergies
4.2 Global Allergic Rhinitis Medication Sales Value by Application
4.2.1 Global Allergic Rhinitis Medication Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Allergic Rhinitis Medication Sales Value, by Application (2019-2030)
4.2.3 Global Allergic Rhinitis Medication Sales Value, by Application (%) (2019-2030)
4.3 Global Allergic Rhinitis Medication Sales Volume by Application
4.3.1 Global Allergic Rhinitis Medication Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Allergic Rhinitis Medication Sales Volume, by Application (2019-2030)
4.3.3 Global Allergic Rhinitis Medication Sales Volume, by Application (%) (2019-2030)
4.4 Global Allergic Rhinitis Medication Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Allergic Rhinitis Medication Sales Value by Region
5.1.1 Global Allergic Rhinitis Medication Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Allergic Rhinitis Medication Sales Value by Region (2019-2024)
5.1.3 Global Allergic Rhinitis Medication Sales Value by Region (2025-2030)
5.1.4 Global Allergic Rhinitis Medication Sales Value by Region (%), (2019-2030)
5.2 Global Allergic Rhinitis Medication Sales Volume by Region
5.2.1 Global Allergic Rhinitis Medication Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Allergic Rhinitis Medication Sales Volume by Region (2019-2024)
5.2.3 Global Allergic Rhinitis Medication Sales Volume by Region (2025-2030)
5.2.4 Global Allergic Rhinitis Medication Sales Volume by Region (%), (2019-2030)
5.3 Global Allergic Rhinitis Medication Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Allergic Rhinitis Medication Sales Value, 2019-2030
5.4.2 North America Allergic Rhinitis Medication Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Allergic Rhinitis Medication Sales Value, 2019-2030
5.5.2 Europe Allergic Rhinitis Medication Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Allergic Rhinitis Medication Sales Value, 2019-2030
5.6.2 Asia Pacific Allergic Rhinitis Medication Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Allergic Rhinitis Medication Sales Value, 2019-2030
5.7.2 South America Allergic Rhinitis Medication Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Allergic Rhinitis Medication Sales Value, 2019-2030
5.8.2 Middle East & Africa Allergic Rhinitis Medication Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Allergic Rhinitis Medication Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Allergic Rhinitis Medication Sales Value
6.2.1 Key Countries/Regions Allergic Rhinitis Medication Sales Value, 2019-2030
6.2.2 Key Countries/Regions Allergic Rhinitis Medication Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Allergic Rhinitis Medication Sales Value, 2019-2030
6.3.2 United States Allergic Rhinitis Medication Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Allergic Rhinitis Medication Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Allergic Rhinitis Medication Sales Value, 2019-2030
6.4.2 Europe Allergic Rhinitis Medication Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Allergic Rhinitis Medication Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Allergic Rhinitis Medication Sales Value, 2019-2030
6.5.2 China Allergic Rhinitis Medication Sales Value by Type (%), 2023 VS 2030
6.5.3 China Allergic Rhinitis Medication Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Allergic Rhinitis Medication Sales Value, 2019-2030
6.6.2 Japan Allergic Rhinitis Medication Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Allergic Rhinitis Medication Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Allergic Rhinitis Medication Sales Value, 2019-2030
6.7.2 South Korea Allergic Rhinitis Medication Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Allergic Rhinitis Medication Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Allergic Rhinitis Medication Sales Value, 2019-2030
6.8.2 Southeast Asia Allergic Rhinitis Medication Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Allergic Rhinitis Medication Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Allergic Rhinitis Medication Sales Value, 2019-2030
6.9.2 India Allergic Rhinitis Medication Sales Value by Type (%), 2023 VS 2030
6.9.3 India Allergic Rhinitis Medication Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Stallergenes Greer
7.1.1 Stallergenes Greer Company Information
7.1.2 Stallergenes Greer Introduction and Business Overview
7.1.3 Stallergenes Greer Allergic Rhinitis Medication Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Stallergenes Greer Allergic Rhinitis Medication Product Offerings
7.1.5 Stallergenes Greer Recent Development
7.2 AstraZeneca
7.2.1 AstraZeneca Company Information
7.2.2 AstraZeneca Introduction and Business Overview
7.2.3 AstraZeneca Allergic Rhinitis Medication Sales, Revenue and Gross Margin (2019-2024)
7.2.4 AstraZeneca Allergic Rhinitis Medication Product Offerings
7.2.5 AstraZeneca Recent Development
7.3 Lotus
7.3.1 Lotus Company Information
7.3.2 Lotus Introduction and Business Overview
7.3.3 Lotus Allergic Rhinitis Medication Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Lotus Allergic Rhinitis Medication Product Offerings
7.3.5 Lotus Recent Development
7.4 GSK
7.4.1 GSK Company Information
7.4.2 GSK Introduction and Business Overview
7.4.3 GSK Allergic Rhinitis Medication Sales, Revenue and Gross Margin (2019-2024)
7.4.4 GSK Allergic Rhinitis Medication Product Offerings
7.4.5 GSK Recent Development
7.5 Neurent Medical
7.5.1 Neurent Medical Company Information
7.5.2 Neurent Medical Introduction and Business Overview
7.5.3 Neurent Medical Allergic Rhinitis Medication Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Neurent Medical Allergic Rhinitis Medication Product Offerings
7.5.5 Neurent Medical Recent Development
7.6 Hikma Pharmaceuticals
7.6.1 Hikma Pharmaceuticals Company Information
7.6.2 Hikma Pharmaceuticals Introduction and Business Overview
7.6.3 Hikma Pharmaceuticals Allergic Rhinitis Medication Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Hikma Pharmaceuticals Allergic Rhinitis Medication Product Offerings
7.6.5 Hikma Pharmaceuticals Recent Development
7.7 Med Globe Therapeutics Limited
7.7.1 Med Globe Therapeutics Limited Company Information
7.7.2 Med Globe Therapeutics Limited Introduction and Business Overview
7.7.3 Med Globe Therapeutics Limited Allergic Rhinitis Medication Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Med Globe Therapeutics Limited Allergic Rhinitis Medication Product Offerings
7.7.5 Med Globe Therapeutics Limited Recent Development
7.8 Bayer Global
7.8.1 Bayer Global Company Information
7.8.2 Bayer Global Introduction and Business Overview
7.8.3 Bayer Global Allergic Rhinitis Medication Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Bayer Global Allergic Rhinitis Medication Product Offerings
7.8.5 Bayer Global Recent Development
7.9 Taiho Pharmaceutical
7.9.1 Taiho Pharmaceutical Company Information
7.9.2 Taiho Pharmaceutical Introduction and Business Overview
7.9.3 Taiho Pharmaceutical Allergic Rhinitis Medication Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Taiho Pharmaceutical Allergic Rhinitis Medication Product Offerings
7.9.5 Taiho Pharmaceutical Recent Development
7.10 Regeneron Pharmaceuticals
7.10.1 Regeneron Pharmaceuticals Company Information
7.10.2 Regeneron Pharmaceuticals Introduction and Business Overview
7.10.3 Regeneron Pharmaceuticals Allergic Rhinitis Medication Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Regeneron Pharmaceuticals Allergic Rhinitis Medication Product Offerings
7.10.5 Regeneron Pharmaceuticals Recent Development
7.11 Glenmark
7.11.1 Glenmark Company Information
7.11.2 Glenmark Introduction and Business Overview
7.11.3 Glenmark Allergic Rhinitis Medication Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Glenmark Allergic Rhinitis Medication Product Offerings
7.11.5 Glenmark Recent Development
8 Industry Chain Analysis
8.1 Allergic Rhinitis Medication Industrial Chain
8.2 Allergic Rhinitis Medication Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Allergic Rhinitis Medication Sales Model
8.5.2 Sales Channel
8.5.3 Allergic Rhinitis Medication Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Allergic Rhinitis Medication Market Trends
    Table 2. Allergic Rhinitis Medication Market Drivers & Opportunity
    Table 3. Allergic Rhinitis Medication Market Challenges
    Table 4. Allergic Rhinitis Medication Market Restraints
    Table 5. Global Allergic Rhinitis Medication Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Allergic Rhinitis Medication Revenue Market Share by Company (2019-2024)
    Table 7. Global Allergic Rhinitis Medication Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Allergic Rhinitis Medication Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Allergic Rhinitis Medication Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Allergic Rhinitis Medication Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Allergic Rhinitis Medication Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Allergic Rhinitis Medication
    Table 13. Global Allergic Rhinitis Medication Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Allergic Rhinitis Medication as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Allergic Rhinitis Medication Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Allergic Rhinitis Medication Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Allergic Rhinitis Medication Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Allergic Rhinitis Medication Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Allergic Rhinitis Medication Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Allergic Rhinitis Medication Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Allergic Rhinitis Medication Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Allergic Rhinitis Medication Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Allergic Rhinitis Medication Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Allergic Rhinitis Medication Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Allergic Rhinitis Medication Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Allergic Rhinitis Medication Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Allergic Rhinitis Medication Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Allergic Rhinitis Medication Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Allergic Rhinitis Medication Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Allergic Rhinitis Medication Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Allergic Rhinitis Medication Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Allergic Rhinitis Medication Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Allergic Rhinitis Medication Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Allergic Rhinitis Medication Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Allergic Rhinitis Medication Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Allergic Rhinitis Medication Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Allergic Rhinitis Medication Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Allergic Rhinitis Medication Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Allergic Rhinitis Medication Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Allergic Rhinitis Medication Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Allergic Rhinitis Medication Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Allergic Rhinitis Medication Sales Value by Region (2019-2024) & (%)
    Table 44. Global Allergic Rhinitis Medication Sales Value by Region (2025-2030) & (%)
    Table 45. Global Allergic Rhinitis Medication Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Allergic Rhinitis Medication Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Allergic Rhinitis Medication Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Allergic Rhinitis Medication Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Allergic Rhinitis Medication Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Allergic Rhinitis Medication Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Allergic Rhinitis Medication Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Allergic Rhinitis Medication Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Allergic Rhinitis Medication Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Allergic Rhinitis Medication Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Allergic Rhinitis Medication Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Allergic Rhinitis Medication Sales Volume, (2025-2030) & (K Units)
    Table 57. Stallergenes Greer Company Information
    Table 58. Stallergenes Greer Introduction and Business Overview
    Table 59. Stallergenes Greer Allergic Rhinitis Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Stallergenes Greer Allergic Rhinitis Medication Product Offerings
    Table 61. Stallergenes Greer Recent Development
    Table 62. AstraZeneca Company Information
    Table 63. AstraZeneca Introduction and Business Overview
    Table 64. AstraZeneca Allergic Rhinitis Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. AstraZeneca Allergic Rhinitis Medication Product Offerings
    Table 66. AstraZeneca Recent Development
    Table 67. Lotus Company Information
    Table 68. Lotus Introduction and Business Overview
    Table 69. Lotus Allergic Rhinitis Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Lotus Allergic Rhinitis Medication Product Offerings
    Table 71. Lotus Recent Development
    Table 72. GSK Company Information
    Table 73. GSK Introduction and Business Overview
    Table 74. GSK Allergic Rhinitis Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. GSK Allergic Rhinitis Medication Product Offerings
    Table 76. GSK Recent Development
    Table 77. Neurent Medical Company Information
    Table 78. Neurent Medical Introduction and Business Overview
    Table 79. Neurent Medical Allergic Rhinitis Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Neurent Medical Allergic Rhinitis Medication Product Offerings
    Table 81. Neurent Medical Recent Development
    Table 82. Hikma Pharmaceuticals Company Information
    Table 83. Hikma Pharmaceuticals Introduction and Business Overview
    Table 84. Hikma Pharmaceuticals Allergic Rhinitis Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. Hikma Pharmaceuticals Allergic Rhinitis Medication Product Offerings
    Table 86. Hikma Pharmaceuticals Recent Development
    Table 87. Med Globe Therapeutics Limited Company Information
    Table 88. Med Globe Therapeutics Limited Introduction and Business Overview
    Table 89. Med Globe Therapeutics Limited Allergic Rhinitis Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Med Globe Therapeutics Limited Allergic Rhinitis Medication Product Offerings
    Table 91. Med Globe Therapeutics Limited Recent Development
    Table 92. Bayer Global Company Information
    Table 93. Bayer Global Introduction and Business Overview
    Table 94. Bayer Global Allergic Rhinitis Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. Bayer Global Allergic Rhinitis Medication Product Offerings
    Table 96. Bayer Global Recent Development
    Table 97. Taiho Pharmaceutical Company Information
    Table 98. Taiho Pharmaceutical Introduction and Business Overview
    Table 99. Taiho Pharmaceutical Allergic Rhinitis Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. Taiho Pharmaceutical Allergic Rhinitis Medication Product Offerings
    Table 101. Taiho Pharmaceutical Recent Development
    Table 102. Regeneron Pharmaceuticals Company Information
    Table 103. Regeneron Pharmaceuticals Introduction and Business Overview
    Table 104. Regeneron Pharmaceuticals Allergic Rhinitis Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. Regeneron Pharmaceuticals Allergic Rhinitis Medication Product Offerings
    Table 106. Regeneron Pharmaceuticals Recent Development
    Table 107. Glenmark Company Information
    Table 108. Glenmark Introduction and Business Overview
    Table 109. Glenmark Allergic Rhinitis Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. Glenmark Allergic Rhinitis Medication Product Offerings
    Table 111. Glenmark Recent Development
    Table 112. Key Raw Materials Lists
    Table 113. Raw Materials Key Suppliers Lists
    Table 114. Allergic Rhinitis Medication Downstream Customers
    Table 115. Allergic Rhinitis Medication Distributors List
    Table 116. Research Programs/Design for This Report
    Table 117. Key Data Information from Secondary Sources
    Table 118. Key Data Information from Primary Sources
List of Figures
    Figure 1. Allergic Rhinitis Medication Product Picture
    Figure 2. Global Allergic Rhinitis Medication Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Allergic Rhinitis Medication Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Allergic Rhinitis Medication Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Allergic Rhinitis Medication Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Allergic Rhinitis Medication Report Years Considered
    Figure 7. Global Allergic Rhinitis Medication Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Allergic Rhinitis Medication Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Allergic Rhinitis Medication Revenue in 2023
    Figure 10. Allergic Rhinitis Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Antihistamines Picture
    Figure 12. Nasal Spray Steroids Picture
    Figure 13. Antileukotrienes Picture
    Figure 14. Global Allergic Rhinitis Medication Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Allergic Rhinitis Medication Sales Value Market Share by Type, 2023 & 2030
    Figure 16. Global Allergic Rhinitis Medication Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 17. Global Allergic Rhinitis Medication Sales Volume Market Share by Type, 2023 & 2030
    Figure 18. Global Allergic Rhinitis Medication Price by Type (2019-2030) & (US$/Unit)
    Figure 19. Product Picture of Seasonal Allergies
    Figure 20. Product Picture of Perennial Allergies
    Figure 21. Global Allergic Rhinitis Medication Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 22. Global Allergic Rhinitis Medication Sales Value Market Share by Application, 2023 & 2030
    Figure 23. Global Allergic Rhinitis Medication Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 24. Global Allergic Rhinitis Medication Sales Volume Market Share by Application, 2023 & 2030
    Figure 25. Global Allergic Rhinitis Medication Price by Application (2019-2030) & (US$/Unit)
    Figure 26. North America Allergic Rhinitis Medication Sales Value (2019-2030) & (US$ Million)
    Figure 27. North America Allergic Rhinitis Medication Sales Value by Country (%), 2023 VS 2030
    Figure 28. Europe Allergic Rhinitis Medication Sales Value (2019-2030) & (US$ Million)
    Figure 29. Europe Allergic Rhinitis Medication Sales Value by Country (%), 2023 VS 2030
    Figure 30. Asia Pacific Allergic Rhinitis Medication Sales Value (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Allergic Rhinitis Medication Sales Value by Country (%), 2023 VS 2030
    Figure 32. South America Allergic Rhinitis Medication Sales Value (2019-2030) & (US$ Million)
    Figure 33. South America Allergic Rhinitis Medication Sales Value by Country (%), 2023 VS 2030
    Figure 34. Middle East & Africa Allergic Rhinitis Medication Sales Value (2019-2030) & (US$ Million)
    Figure 35. Middle East & Africa Allergic Rhinitis Medication Sales Value by Country (%), 2023 VS 2030
    Figure 36. Key Countries/Regions Allergic Rhinitis Medication Sales Value (%), (2019-2030)
    Figure 37. Key Countries/Regions Allergic Rhinitis Medication Sales Volume (%), (2019-2030)
    Figure 38. United States Allergic Rhinitis Medication Sales Value, (2019-2030) & (US$ Million)
    Figure 39. United States Allergic Rhinitis Medication Sales Value by Type (%), 2023 VS 2030
    Figure 40. United States Allergic Rhinitis Medication Sales Value by Application (%), 2023 VS 2030
    Figure 41. Europe Allergic Rhinitis Medication Sales Value, (2019-2030) & (US$ Million)
    Figure 42. Europe Allergic Rhinitis Medication Sales Value by Type (%), 2023 VS 2030
    Figure 43. Europe Allergic Rhinitis Medication Sales Value by Application (%), 2023 VS 2030
    Figure 44. China Allergic Rhinitis Medication Sales Value, (2019-2030) & (US$ Million)
    Figure 45. China Allergic Rhinitis Medication Sales Value by Type (%), 2023 VS 2030
    Figure 46. China Allergic Rhinitis Medication Sales Value by Application (%), 2023 VS 2030
    Figure 47. Japan Allergic Rhinitis Medication Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Japan Allergic Rhinitis Medication Sales Value by Type (%), 2023 VS 2030
    Figure 49. Japan Allergic Rhinitis Medication Sales Value by Application (%), 2023 VS 2030
    Figure 50. South Korea Allergic Rhinitis Medication Sales Value, (2019-2030) & (US$ Million)
    Figure 51. South Korea Allergic Rhinitis Medication Sales Value by Type (%), 2023 VS 2030
    Figure 52. South Korea Allergic Rhinitis Medication Sales Value by Application (%), 2023 VS 2030
    Figure 53. Southeast Asia Allergic Rhinitis Medication Sales Value, (2019-2030) & (US$ Million)
    Figure 54. Southeast Asia Allergic Rhinitis Medication Sales Value by Type (%), 2023 VS 2030
    Figure 55. Southeast Asia Allergic Rhinitis Medication Sales Value by Application (%), 2023 VS 2030
    Figure 56. India Allergic Rhinitis Medication Sales Value, (2019-2030) & (US$ Million)
    Figure 57. India Allergic Rhinitis Medication Sales Value by Type (%), 2023 VS 2030
    Figure 58. India Allergic Rhinitis Medication Sales Value by Application (%), 2023 VS 2030
    Figure 59. Allergic Rhinitis Medication Industrial Chain
    Figure 60. Allergic Rhinitis Medication Manufacturing Cost Structure
    Figure 61. Channels of Distribution (Direct Sales, and Distribution)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS